Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Trump administration urged to take on China's 'Pharma Death Grip
The push comes as policymakers recognize the United States relies heavily on China for key pharmaceutical materials, particularly the raw components of many antibiotics, while producing a small share domestically, China specialist Gordon Chang…
AP Shills For Big Pharma Antidepressants With 'Bewildering' Hit Piece
Check this out... The Trump FDA's top drug regulator, Dr. Tracy Beth Hoeg, is working to hire a researcher and friend who strongly believes the agency should add new warnings about antidepressants and pregnancy risks. So what does the Associated…
China focus: a2 Milk Company, Otsuka Pharma, HMO approval and more
This round-up looks at news from a2 Milk Company and Otsuka Pharma, the third HMO approval in China, latest scientific findings and more.
Mayne Pharma Group Limited (MAYNF) Discusses U.S. Launch and Business Model of DistributeRx Transcript
Mayne Pharma Group Limited (MAYNF) Discusses U.S. Launch and Business Model of DistributeRx March 10, 2026 8:01 PM EDT Thomas Duthy - Manager of Investor Relations Aaron Gray - Chief Executive Officer Andrew Goodsall - MST Financial Services Pty…
HC Wainwright Raises Earnings Estimates for BridgeBio Pharma
BridgeBio's Volatile Week Puts Biotech Stocks Under a Microscope BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) - Analysts at HC Wainwright raised their Q1 2026 earnings estimates for BridgeBio Pharma in a report released on Monday, March 9th.
Nuvectis Pharma (NASDAQ:NVCT) Shares Up 6.3% - Still a Buy?
Nuvectis Pharma, Inc. (NASDAQ:NVCT - Get Free Report)'s stock price shot up 6.3% on Tuesday. The company traded as high as $9.88 and last traded at $9.65. 94,856 shares traded hands during trading, an increase of 86% from the average session volume…
Louis Lange Sells 28,186 Shares of NewAmsterdam Pharma (NASDAQ:NAMS) Stock
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Get Free Report) Director Louis Lange sold 28,186 shares of the stock in a transaction on Friday, March 6th. The stock was sold at an average price of $29.41, for a total value of $828,950.26. The…
Ascendis Pharma A/S $ASND Position Increased by Capital International Investors
Capital International Investors boosted its position in shares of Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 0.4% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The…
Spyglass Pharma, Inc.'s Quiet Period Will Expire on March 18th (NASDAQ:SGP)
Spyglass Pharma's (NASDAQ:SGP - Get Free Report) quiet period will end on Wednesday, March 18th. Spyglass Pharma had issued 9,375,000 shares in its initial public offering on February 6th. The total size of the offering was $150,000,000 based on an…
Capital International Investors Raises Stock Holdings in Royalty Pharma PLC $RPRX
Capital International Investors boosted its position in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 24.4% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 27,212,694…
BridgeBio Pharma (NASDAQ:BBIO) Trading Up 9.3% - Should You Buy?
Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Get Free Report) shot up 9.3% on Tuesday. The company traded as high as $70.49 and last traded at $71.7590. 1,265,413 shares traded hands during mid-day trading, a decline of 60% from the average…
WINTON GROUP Ltd Takes $3.36 Million Position in Royalty Pharma PLC $RPRX
WINTON GROUP Ltd purchased a new stake in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor…
NewAmsterdam Pharma Company N.V. $NAMS Shares Bought by American Century Companies Inc.
American Century Companies Inc. lifted its position in shares of NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Free Report) by 17.1% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 624,285 shares of the…
MNCs, Indian drugmakers diverge to mutual gain: How win-win is it?
The Novartis move is new in that it marks the first such total exit by an MNC in the Indian pharma market — partial divestments have been happening for years. The clearest signal came last month when Novartis decided to exit its listed arm.
Harbor Health Care ETF Q4 2025 Commentary (MEDI)
During the fourth quarter, the Harbor Health Care ETF returned 10.43% (NAV), underperforming the Russell 3000 Growth Health Care Index, which returned 16.71%. The underperformance was primarily driven by stock selection and relative underexposure…
Receive a Daily briefing on Pharma Industry News
Get Started